CCP
TECH icon

Clarkston Capital Partners’s Bio-Techne TECH Stock Holding History

Clarkston Capital Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,400
Closed -$222K – 142
2014
Q1 		$222K Hold
10,400
– – 0.04% 140
2013
Q4 		$246K Buy
+10,400
New +$225K 0.1% 105

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Clarkston Capital Partners's TECH Position: Q2 2014 in Review

Clarkston Capital Partners sold out of Bio-Techne (TECH) in Q2 2014, closing a stake of 10,400 shares — an estimated $222K sold.

Clarkston Capital Partners first reported a position in TECH in Q4 2013 and held it in 2 quarters. The position peaked at $246K in Q4 2013. 237 funds tracked by Wall St. Rank hold TECH as of Q2 2014.

  • Clarkston Capital Partners reported no remaining Bio-Techne position as of Q2 2014 after selling out during the quarter.
  • Clarkston Capital Partners sold 10,400 Bio-Techne shares in Q2 2014, an estimated $222K.
  • Clarkston Capital Partners first reported a position in Bio-Techne in Q4 2013 and held it in 2 quarters.
  • Clarkston Capital Partners's Bio-Techne position peaked at $246K in Q4 2013.
  • 237 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2014.

Based on Clarkston Capital Partners's 13F filing for Q2 2014, filed 16 Jul 2014.